Keywords: astrazeneca, zomig, top, triptan, europe, anglo-swedish, drug
AstraZeneca's Zomig is top triptan in Europe
Article | 08 March 2004
Anglo-Swedish drug major AstraZeneca has reported that its Zomig (zolmitriptan) has taken over from sumatriptan as the most-prescribed triptan (5-HT 1 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
